The effect of dexamethasone (and IL-6 blockers) on ICU mortality was seen mainly in settings with a rather high COVID ICU mortality of 30% (UK, NL) whereas the effect might not be significant in settings with already a low COVID ICU mortality rate like 13% (Norway, BE).
1
—
—